Health Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026 October 24, 2026
Health Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026 October 24, 2026
Health Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA October 23, 2026
Health Aveanna Announces Third Quarter 2026 Earnings Release Date and Conference Call October 22, 2026
Health Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies October 22, 2026
Health [Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +8% in CHF; Group sales increase +6% (CER), +1% in CHF, in the first nine […] October 22, 2026
Health ONWARD Medical Announces the Appointment of Fouad Azzam to its Board of Directors October 21, 2026
Health Yakira Capital Management Calls on Atrium Therapeutics to Launch Strategic Review, Curb Cash Spending and Explain Dilutive Financing October 20, 2026
Search
Health
October 24, 2026
October 24, 2026
October 24, 2026
October 23, 2026
October 22, 2026
October 22, 2026
![[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +8% in CHF; Group sales increase +6% (CER), +1% in CHF, in the first nine […]](https://stockstreetnews.com/wp-content/uploads/2026/10/5dabc53fc228786bc0ea8be435559524-336x223.jpg)
October 22, 2026
October 21, 2026
October 21, 2026
October 20, 2026
